Ingro Finanz AG is an investment holding company specialized in late stage venture investments.
Ingro Finance AG is a privately held Swiss company focusing on the purchase,
administration and divestment of all types of participations. The investment portfolio of the
company comprises amongst others participations in various life science companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 12, 2009
![]() |
Series Unknown | $54.80M | Biotechnology | — |
Sep 24, 2007
![]() |
Series C | €33.70M | Biopharma | — |
Ingro Finanz AG has had 1 exits. Ingro Finanz AG most notable exits include Ganymed Pharmaceuticals
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 28, 2016 | Ganymed Pharmaceuticals | M&A | Biopharma | Detail |